Kidney transplantation from deceased donors with HIV to people living with both HIV and end-stage kidney disease is feasible and safe, investigators supported by the National Institutes of Health have found.
NIH
NIH leadership details unprecedented initiative to ramp up testing technologies for COVID-19
In a paper in the New England Journal of Medicine(link is external), scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease.
NIH launches analytics platform to harness nationwide COVID-19 patient data to speed treatments
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
Low-dose aspirin may reduce preterm birth risk among first-time mothers
Daily low-dose aspirin, from as early as the sixth week of pregnancy through the 36th week, may lower the risk for preterm birth among first-time mothers, suggests a study funded by the National Institutes of Health.
Zinc, folic acid supplement does not improve male fertility, NIH study suggests
Dietary supplements containing zinc and folic acid — marketed as a treatment for male infertility — do not appear to improve pregnancy rates, sperm counts or sperm function, according to a study conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health. The study appears in the Journal of the American Medical Association.
Efforts to end the HIV epidemic must not ignore people already living with HIV
NIH experts have highlight that efforts to prevent new HIV transmissions in the United States must be accompanied by advances in addressing HIV-associated comorbidities to improve the health of people already living with HIV,
NIH names Dr. Debara L. Tucci as the next director of the National Institute on Deafness and Other Communication Disorders
National Institutes of Health Director Francis S. Collins, M.D., Ph.D., has selected Debara L. Tucci, M.D., M.S., M.B.A., to lead the National Institute on Deafness and Other Communication Disorders (NIDCD) as its new director.
